BioSpace News Archive

The Insight Partners published latest research report on “Blood Plasma Derivatives Market Size Report, Growth, Trends and Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Application, and End User,” the global market size is expected to reach USD 51,119.24 million by 2028 from USD 29.886.12 million in 2022; it is estimated to record a CAGR of 9.4% from 2022 to 2028.

Certain stem cells have a unique ability to move between growth compartments in hair follicles, but get stuck as people age and so lose their ability to mature and maintain hair color, a new study shows.

Alphatec Holdings, Inc. announced that it has acquired all assets related to the REMI Robotic Navigation System from Fusion Robotics, LLC, a privately held medical technology company, for a purchase price of $55 million.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company is scheduled to release its first quarter 2023 financial results after the market closes on Wednesday, April 26, 2023.

InnoCare Pharma, a leading biopharmaceutical company, announced that its BTK inhibitor orelabrutinib received approval from the China National Medical Products Administration in the treatment of patients with relapsed/refractory marginal zone lymphoma.